Brassica napus: The Plant Behind PhytoFactor

Brassica napus is a flowering plant in the family Brassicaceae — the mustard or cabbage family — grown worldwide as an oilseed crop under the names rapeseed and, in its low-erucic-acid cultivars, canola. It is the second-largest oilseed crop on earth after soybean. Since the mid-2020s it has also carried a second identity in the dietary supplement category: its seeds are the source of PhytoFactor™, the first plant-based transfer factor ingredient, and 300 mg of every daily serving of 4Life Transfer Factor Max.*

This article is about the plant itself — where it came from, why a seed rather than a leaf or a root, why the oil is a red herring, and what the current evidence for the extract does and does not establish. Here's the version we'd want our own family to read before deciding whether the plant-based half of the formula means anything.

What Brassica napus actually is

Most people have eaten Brassica napus without knowing its name. It is the plant behind canola oil, and — in a different subspecies — behind the rutabaga in a winter stew. In flower it is the crop responsible for those saturated yellow fields that photograph so well across the English countryside and the Canadian prairie in May.

Botanically, it is more interesting than its ubiquity suggests. B. napus is not an ancient wild species. It is an allotetraploid — a hybrid that formed when two different diploid parents crossed and the offspring retained both complete genomes rather than halving them. Its parents are two plants most kitchens already know:

• Brassica rapa (AA, 2n = 20) — turnip rape, and the ancestor of bok choy, napa cabbage, and the turnip.
• Brassica oleracea (CC, 2n = 18) — the single species that domestication turned into cabbage, kale, broccoli, cauliflower, Brussels sprouts, and kohlrabi.

The cross produced a plant carrying both genomes at once: AACC, 2n = 38. Whole-genome resequencing work places the hybridization event somewhere in the window of roughly 6,800 to 12,500 years ago — recent enough, in evolutionary terms, that B. napus is effectively a post-Neolithic species that arose alongside agriculture rather than long before it.

Three subspecies are recognized today: oleifera (the oilseed rape grown for canola), rapifera (rutabaga or swede), and pabularia (Siberian kale, or leaf rape). PhytoFactor is sourced from the oilseed type — specifically, from its seeds.

Why a seed — and why not the oil

This is the single most common point of confusion, so it is worth being blunt about it: PhytoFactor is not canola oil, and canola oil is not PhytoFactor. They originate in the same seed and are otherwise unrelated.

A rapeseed is, functionally, a survival package. It carries everything a seedling needs to establish itself before it can photosynthesize — stored lipids for energy, storage proteins, and a set of defensive and signaling compounds that protect the embryo during the vulnerable window between germination and establishment. Crush the seed and press it, and you extract the lipid fraction: that is canola oil, and it is what the global commodity market wants from this plant.

The peptide fraction is a different target entirely. PhytoFactor is a peptide-containing extract of the seed, isolated by a process 4Life has not published in full. What 4Life does claim is that this fraction carries transfer factor activity — the same class of small immune-signaling peptides previously known only from bovine colostrum and hen egg yolk.*

The practical takeaway: if you have decided to avoid canola oil for dietary or culinary reasons, that decision does not automatically extend to a seed peptide extract. They are different substances doing different jobs. If the distinction matters to you, ask 4Life customer service for the ingredient specification rather than reasoning from the plant name alone.

Why 4Life went looking in a plant at all

For roughly twenty-five years, commercial transfer factor had exactly one origin story: mammals and birds. 4Life's original 1998 product drew on bovine colostrum, the antibody-dense first milk a cow produces after calving. Hen egg yolk was added later. Refinement of those two sources produced the three branded fractions — UltraFactor XF®, NanoFactor®, and OvoFactor® — that together make the Tri-Factor® Formula.

An animal-only supply chain has structural limits. It is tied to livestock cycles, it carries obvious constraints for anyone avoiding dairy or egg, and it caps how much source material a company can secure. Finding transfer factor activity in a widely farmed oilseed changes all three of those variables at once.

But the more interesting claim is not about supply. 4Life's position is that PhytoFactor does something the animal-derived fractions do not. In the company's preclinical work, PhytoFactor showed a more direct effect on invading organisms, in addition to functioning as an immune messenger the way animal transfer factors do.* That is why Max combines the two sources rather than swapping one for the other — the 600 mg of Tri-Factor stays, and the 300 mg of PhytoFactor is added on top.

The mechanistic comparison between the two source types is its own subject, and we have covered it separately: PhytoFactor vs animal transfer factor — the mechanism difference.*

Where PhytoFactor appears across the 4Life line

Transfer Factor Max is the flagship, but it is not the only place the plant shows up. Three products currently carry PhytoFactor:

Because the three were designed as a system rather than as competitors, there is no formulation conflict in taking more than one. Details on each are on our other formulas page.

What the evidence establishes — and what it doesn't

This is the section most ingredient-origin articles skip, and it is the one that should decide your purchase. The honest picture has three tiers.

Tier 1 · Independent, peer-reviewed — but not about the plant

The strongest paper in this category is Yu et al., 2024, published in Current Issues in Molecular Biology, which found measurable changes in immune surveillance and cytokine markers within two hours of a single serving. It is peer-reviewed and academically conducted, and it is the source of the "activates in 2 hours" claim. But read the title carefully: it studied colostrum- and egg-based low-molecular-weight peptides. That is the animal side of the formula. Yu 2024 is not a PhytoFactor study.

Tier 2 · Company-authored documents about the finished formula

Gardner et al., 2026 (a 4Life technical white paper) documents immune stem cell mobilization, and Jensen et al., 2026 (Clinical Report 058-010) documents neutrophil activation. Both concern the Max formula as sold — which does contain PhytoFactor — but both are company-affiliated rather than independently peer-reviewed. They sit a tier below Yu 2024 and should be weighted accordingly.

Tier 3 · The gap

There is, at the time of writing, no published peer-reviewed human trial isolating PhytoFactor as a single ingredient. The "more direct effect on invading organisms" claim comes from preclinical company work. Preclinical means laboratory or animal models, not people. That is a real and material limitation, and anyone telling you otherwise is overselling.

None of this makes the ingredient uninteresting. A genuinely novel plant source of a peptide class previously restricted to animals is a legitimate development, and the finished formula does carry supporting documentation. It does mean the correct posture is interest rather than certainty. Our full evidence tiering, study by study, is here: the clinical studies behind Transfer Factor Max, explained.*

Frequently Asked Questions

*These statements have not been evaluated by the Food and Drug Administration. Transfer Factor Max is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult your healthcare provider before beginning any new supplement program.